(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

EXODISCOVERY

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

EXODISCOVERY

ST13

US500000079360395

Classe

10, 35, 44

Pedido

79360395

Registro

7416325

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

26

Atualização mais recente

03/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

10, 35, 44

Data de depósito

05/12/2022

Data de registro

18/06/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

18/06/2024

Última transação

03/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

03

Localização do titular

KR

Examinador

MCCAULEY, BRENDAN D

Unidade examinadora

M50

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

LabSpinner Inc.

Representantes

Sangwon Kim REVOLUTION IP, PLLC

Classificação técnica

Classes Nice

Classe 10Classe 35Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 10

Test equipment for medical useblood testing apparatuseye testing apparatusmulti-drug cups for drug use testing purposes; medical centrifuge other than for dental purposes in the nature of blood component separation apparatus for medical purposes

Classe 35

Wholesale store services featuring reagents and media for medical and veterinary diagnostic purposes; wholesale store services featuring diagnostic preparations for medical and veterinary use; wholesale store services featuring chemical reagents for medical or veterinary purposes; wholesale store services featuring diagnostic reagents for medical or veterinary purposes; wholesale store services featuring diagnostic preparations for medical purposes; wholesale store services featuring diagnostic chemical reagents for medical use; wholesale store services featuring clinical medical reagents; wholesale store services featuring medical apparatus and instruments for RNA analysis other than for dental purposes; wholesale store services featuring test equipment for medical use; wholesale store services featuring body fluid analysis apparatus for medical purposes; wholesale store services featuring medical centrifuge other than for dental purposes; wholesale store services featuring medical apparatus and instruments in the fields of clinical diagnosis; wholesale store services featuring diagnostic apparatus and instruments for medical purposes; wholesale store services featuring blood analysis apparatus for diagnosis; wholesale store services featuring plasma separators; retail store services featuring diagnostic preparations for medical or veterinary purposes; retail store services featuring diagnostic preparations for medical purposes; retail store services featuring clinical medical reagents; retail store services featuring pharmaceutical preparations for diagnosis

Classe 44

Medical analysis services relating to the treatment of persons; pathology servicesmedical diagnosis and treatment of cancer; pathology servicesspeech pathology therapy services; medical analysis for the diagnosis and treatment of persons; RNA or DNA medical analysis for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; medical analysis services for the diagnosis of cancer; providing cancer screening services; providing information in the field of cancer preventionscreeningdiagnosis and treatment; medical diagnostic servicesmedical testing for diagnostic purposes and medical analysis for the diagnosis and treatment of persons; medical services in the field of oncology; medical testing services relating to the diagnosis and treatment of disease; performing diagnosis of diseases

Publicações

Histórico de despachos e eventos da marca no USPTO.

26 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

14/12/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

25/11/2024

FIMP

FINAL DISPOSITION PROCESSED

25/11/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

18/09/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

18/06/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

18/06/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

10/06/2024

GPNX

NOTIFICATION PROCESSED BY IB

15/04/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/04/2024

PUBO

PUBLISHED FOR OPPOSITION

02/04/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

27/03/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

27/03/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

13/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

28/02/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

27/02/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

27/02/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

27/02/2024

RFNT

REFUSAL PROCESSED BY IB

07/11/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

14/10/2023

RFRR

REFUSAL PROCESSED BY MPU

14/10/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

14/09/2023

CNRT

NON-FINAL ACTION WRITTEN

13/09/2023

DOCK

ASSIGNED TO EXAMINER

12/09/2023

MAFR

APPLICATION FILING RECEIPT MAILED

18/01/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

14/01/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/01/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace EXODISCOVERY ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.